Validation of genotype array analysis for the assessment of homologous recombination deficiency (HRD) in epithelial ovarian cancer

被引：0
|
作者：
Schnaiter, Simon [1 ]
Schamschula, Esther [1 ]
Zschocke, Johannes [1 ]
Fiegl, Heidi [2 ]
Reimer, Daniel U. [2 ]
Zeimet, Alain [2 ]
Wimmer, Katharina [1 ]
机构：
[1] Med Univ Innsbruck, Inst Human Genet, Innsbruck, Austria
[2] Med Univ Innsbruck, Dept Obstet & Gynecol, Innsbruck, Austria
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2023年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P13.091.A
引用
收藏
页码：555 / 556
页数：2
相关论文
共 50 条
  • [1] Global-screening array for the assessment of homologous recombination deficiency (HRD) in epithelial ovarian cancer
    Schnaiter, Simon
    Schamschula, Esther
    Fiegl, Heidelinde
    Reimer, Daniel
    Zeimet, Alain
    Zschocke, Johannes
    Wimmer, Katharina
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 402 - 403
  • [2] Homologous recombination deficiency in epithelial ovarian cancer
    Thomas Bartl
    Valentina Paspalj
    Christoph Grimm
    memo - Magazine of European Medical Oncology, 2020, 13 : 367 - 370
  • [3] Homologous recombination deficiency in epithelial ovarian cancer
    Bartl, Thomas
    Paspalj, Valentina
    Grimm, Christoph
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (04) : 367 - 370
  • [4] Assessment of Homologous Recombination Deficiency in Ovarian Cancer
    Garg, Vikas
    Oza, Amit M.
    CLINICAL CANCER RESEARCH, 2023, 29 (16) : 2957 - 2960
  • [5] Homologous recombination deficiency (HRD) testing on ovarian cancer ascites: A feasibility study
    Ranghiero, A.
    Rocco, E. Guerini
    Rappa, A.
    Varcica, D.
    Taormina, S. V.
    Adorisio, R.
    Marinucci, L.
    Betella, I.
    Aletti, G.
    Colombo, N.
    Fusco, N.
    Casadio, C.
    Di Tonno, C.
    Barberis, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S717 - S717
  • [6] Characterization of epithelial ovarian cancer based on multigene tumor testing and homologous recombination deficiency (HRD) testing (COMBO)
    Spenard, Elisabeth
    Care, Melanie
    McCuaig, Jeanna
    Clarke, Blaise
    Kim, Raymond
    Ferguson, Sarah
    Ranich, Laura
    Stockley, Tracy
    Bernardini, Marcus
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S162 - S162
  • [7] Pregnancy and miscarriage in epithelial ovarian cancer (EOC) patients harboring mutational signature of homologous recombination deficiency (HRD)
    Incorvaia, L.
    Russo, T. D. Bazan
    Perez, A.
    Brando, C.
    Ferraro, P.
    Simone, A.
    Bono, M.
    Castellana, L.
    Insalaco, L.
    Contino, S.
    Gottardo, A.
    Gristina, V.
    Galvano, A.
    Corsini, L. R.
    Fanale, D.
    Badalamenti, G.
    Russo, A.
    Bazan, V.
    ANNALS OF ONCOLOGY, 2024, 35 : S955 - S955
  • [8] The impact of homologous recombination deficiency on the prognosis of epithelial ovarian cancer
    Su, Haiqi
    Wang, Yinan
    Chao, Xiaopei
    Wu, Huanwen
    You, Yan
    Zhao, Shuru
    Wang, Feiyue
    Sun, Bao
    Zhang, Zhen
    Wu, Ming
    Zhao, Zicheng
    Li, Lei
    CLINICAL AND TRANSLATIONAL MEDICINE, 2025, 15 (01):
  • [9] Clinical Utility of Homologous Recombination Deficiency (HRD) Profiling in Ovarian Cancer: An Indian Experience
    Bahadur, U.
    Ravichandran, A.
    Basu, S.
    Nayanala, S.
    Vishwanath, D.
    Muniyappa, N.
    Neelagandan, B. G. K.
    Ramkumar, A. N. J. A.
    Sajjad, S.
    Nair, R. H. J. J.
    Krishnan, G.
    Ramanathan, V. G. R. A.
    Chatterjee, A.
    Sridharan, S.
    Phalke, S.
    Veeramachaneni, V.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S106 - S106
  • [10] Homologous recombination deficiency (HRD) score and niraparib efficacy in high grade ovarian cancer
    Haluska, P.
    Timms, K. M.
    AlHilli, M.
    Wang, Y.
    Hartman, A. M.
    Jones, J.
    Gutin, A.
    Sangale, Z.
    Neff, C.
    Lynchbury, J.
    Rudolph-Owen, L.
    Becker, M. A.
    Agarwal, S.
    Wilcoxen, K. M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 72 - 73
12345